Literature DB >> 19383343

Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells.

Olga Ch Kousidou1, Aikaterini Berdiaki, Dimitris Kletsas, Alexandros Zafiropoulos, Achilleas D Theocharis, George N Tzanakakis, Nikos K Karamanos.   

Abstract

Estrogens are related with the growth and development of target tissues and play a critical role in breast cancer progression. The effects of estrogens are mediated by the estrogen receptors ERalpha and ERbeta, which are members of the nuclear steroid receptor superfamily. To date, it is not known how these hormones elicit many of their effects on extracellular matrix molecules and how these effects can be connected with ER expression. For this purpose, the effect of estradiol on ER expression as well as on proteoglycan and metalloproteinase expression was studied. The effect of E2 on extracellular matrix molecule expression has been studied using ERalpha suppression in breast cancer cells. Our studies using ERalpha-positive MCF-7 cells show that estradiol affects the expression of syndecan-2, but not of syndecan-4, through ERalpha. Furthermore, the ability of estradiol to affect MMP-9 and TIMP-1 expression is connected with ERalpha status. Together, these data demonstrate the significant role of ERalpha on mediating the effect of estradiol on extracellular matrix molecules.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19383343      PMCID: PMC5527808          DOI: 10.1016/j.molonc.2008.06.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  48 in total

1.  The ontogeny and cellular distribution of estrogen receptors in normal mouse mammary gland.

Authors:  S Z Haslam; K A Nummy
Journal:  J Steroid Biochem Mol Biol       Date:  1992-07       Impact factor: 4.292

2.  MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells.

Authors:  Ulrika W Nilsson; Stina Garvin; Charlotta Dabrosin
Journal:  Breast Cancer Res Treat       Date:  2006-10-10       Impact factor: 4.872

3.  Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells.

Authors:  Olga Ch Kousidou; Aikaterini Berdiaki; Dimitris Kletsas; Alexandros Zafiropoulos; Achilleas D Theocharis; George N Tzanakakis; Nikos K Karamanos
Journal:  Mol Oncol       Date:  2008-06-18       Impact factor: 6.603

Review 4.  Estrogen receptor beta in breast cancer.

Authors:  C Palmieri; G J Cheng; S Saji; M Zelada-Hedman; A Wärri; Z Weihua; S Van Noorden; T Wahlstrom; R C Coombes; M Warner; J-A Gustafsson
Journal:  Endocr Relat Cancer       Date:  2002-03       Impact factor: 5.678

5.  17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells.

Authors:  C S Wingrove; E Garr; I F Godsland; J C Stevenson
Journal:  Biochim Biophys Acta       Date:  1998-03-05

6.  Tissue inhibitor of metalloprotease (TIMP)-1 and proliferative behaviour of clonal breast cancer cells.

Authors:  C Luparello; G Avanzato; C Carella; I Pucci-Minafra
Journal:  Breast Cancer Res Treat       Date:  1999-04       Impact factor: 4.872

Review 7.  Syndecan-2.

Authors:  Jeffrey J Essner; Eleanor Chen; Stephen C Ekker
Journal:  Int J Biochem Cell Biol       Date:  2005-09-15       Impact factor: 5.085

8.  Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid.

Authors:  H G Welgus; G P Stricklin
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

9.  Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells.

Authors:  F Capony; M Morisset; A J Barrett; J P Capony; P Broquet; F Vignon; M Chambon; P Louisot; H Rochefort
Journal:  J Cell Biol       Date:  1987-02       Impact factor: 10.539

Review 10.  Reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland.

Authors:  S Z Haslam; T L Woodward
Journal:  Breast Cancer Res       Date:  2001-08-02       Impact factor: 6.466

View more
  27 in total

1.  Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells.

Authors:  Olga Ch Kousidou; Aikaterini Berdiaki; Dimitris Kletsas; Alexandros Zafiropoulos; Achilleas D Theocharis; George N Tzanakakis; Nikos K Karamanos
Journal:  Mol Oncol       Date:  2008-06-18       Impact factor: 6.603

2.  Integrated quantitative analysis of the phosphoproteome and transcriptome in tamoxifen-resistant breast cancer.

Authors:  Masaaki Oyama; Takeshi Nagashima; Takashi Suzuki; Hiroko Kozuka-Hata; Noriko Yumoto; Yuichi Shiraishi; Kazuhiro Ikeda; Yoko Kuroki; Noriko Gotoh; Takanori Ishida; Satoshi Inoue; Hiroaki Kitano; Mariko Okada-Hatakeyama
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

Review 3.  Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.

Authors:  Achilleas D Theocharis; Spyros S Skandalis; Thomas Neill; Hinke A B Multhaupt; Mario Hubo; Helena Frey; Sandeep Gopal; Angélica Gomes; Nikos Afratis; Hooi Ching Lim; John R Couchman; Jorge Filmus; Ralph D Sanderson; Liliana Schaefer; Renato V Iozzo; Nikos K Karamanos
Journal:  Biochim Biophys Acta       Date:  2015-03-28

4.  Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells.

Authors:  Ravinder Tammali; Ashish Saxena; Satish K Srivastava; Kota V Ramana
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

5.  Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36).

Authors:  Reyhaan A Chaudhri; Rene Olivares-Navarrete; Natalia Cuenca; Agreen Hadadi; Barbara D Boyan; Zvi Schwartz
Journal:  J Biol Chem       Date:  2012-01-13       Impact factor: 5.157

6.  Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.

Authors:  Rachel K Okolicsanyi; Andre J van Wijnen; Simon M Cool; Gary S Stein; Lyn R Griffiths; Larisa M Haupt
Journal:  J Cell Biochem       Date:  2014-05       Impact factor: 4.429

Review 7.  Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans.

Authors:  Atsuko Yoneda; Maria E Lendorf; John R Couchman; Hinke A B Multhaupt
Journal:  J Histochem Cytochem       Date:  2012-01       Impact factor: 2.479

8.  Extracellular signal-regulated kinase 8 (ERK8) controls estrogen-related receptor α (ERRα) cellular localization and inhibits its transcriptional activity.

Authors:  Matteo Rossi; David Colecchia; Carlo Iavarone; Angela Strambi; Federica Piccioni; Arturo Verrotti di Pianella; Mario Chiariello
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

9.  Pregnancy-induced gingivitis and OMICS in dentistry: in silico modeling and in vivo prospective validation of estradiol-modulated inflammatory biomarkers.

Authors:  Mervi Gürsoy; Fares Zeidán-Chuliá; Eija Könönen; José C F Moreira; Joonas Liukkonen; Timo Sorsa; Ulvi K Gürsoy
Journal:  OMICS       Date:  2014-07-01

Review 10.  Proteoglycans: Potential Agents in Mammographic Density and the Associated Breast Cancer Risk.

Authors:  Michael S Shawky; Carmela Ricciardelli; Megan Lord; John Whitelock; Vito Ferro; Kara Britt; Erik W Thompson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-12       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.